| Melatonin, sleep aid that may fight cancer
|
2005-10-06 Judy Foreman - The Boston Globe
Melatonin, long known to insomniacs as
an over-the-counter sleep aid, is now being studied as a way to
prevent and treat breast and other cancers.
Dubbed the "hormone of darkness,"
melatonin is made by the brain's pineal gland at night. This summer,
researchers at Brigham and Women's Hospital in Boston led by Dr. Eva
Schernhammer, an epidemiologist, showed that women who produced the
lowest levels of melatonin were 70 percent more likely to get breast
cancer than those with the highest levels. Schernhammer's group previously showed
that women who work at night are at higher risk of both breast and
colon cancer. Light at night can shut off melatonin production. A study to be published this autumn
explores whether women who sleep nine hours or more a night -
enabling them to produce more than the average amount of melatonin -
are at lower than average risk of breast cancer. A co-author of that study, the cancer
epidemiologist Richard Stevens of the University of Connecticut
Health Center in Farmington, said breast cancer rates were much
higher in industrialized countries, where, among other things, people
routinely use a lot of artificial light at night, which suppresses
melatonin production. "We can't say yet, but the
evidence is accumulating that light at night, and the consequent
decrease in melatonin, may be a major driver of breast cancer,"
he said. From an evolutionary point of view,
melatonin may have developed as a signal to tell animals when to
breed. In sheep, melatonin levels rise in autumn as the nights get
longer. Melatonin is also an important
regulator of the circadian clock in the brain, which keeps the body
on a regular cycle of day and night. Light, whether from the sun or
electric lights, suppresses melatonin production. But when light
disappears, and darkness falls, there's a cascade of nerve signals
from the eye to the pineal gland, which then starts making melatonin.
That's why melatonin has been popularized as a sleep aid. Frustrated by the high rates of breast
cancer in industrialized countries, Stevens of UConn hypothesized in
the late 1980s that light at night might spur cancer growth and that
melatonin might protect against it.
"We know that if you take out the
pineal gland in animals, that removes all melatonin, and then if you
inject cancer cells, the cancer growth rate increases," said
Steven Lockley, a neuroscientist at Brigham and Women's, who is now
studying the melatonin levels and breast cancer rates of women who
are blind. "We know that when you put an animal in constant
light, that also stops all melatonin production, and you get a
similar response. And if you then treat an animal with melatonin, you
can slow down the cancer rate."
Researchers are just now starting to
look at the treatment potential for melatonin. At the Bassett
Research Institute in Cooperstown, New York, Dr. David Blask, a
senior research scientist, reported at a cancer meeting this summer
that melatonin can "put cancer cells to sleep" by blocking
their ability to soak up linoleic acid, which makes cancer cells grow
rapidly. In animal studies, Blask said he had found that cancer cell
growth is slower at night, when melatonin is highest, and faster
during the day. He also found that adding melatonin to human breast
cancer cells grown in rats can slow the cancer's growth.
In Europe, studies of people with
cancer who are given melatonin are also promising, though
preliminary. Melatonin appears able not only to slow cancer
progression and improve survival in advanced cancer patients, but to
protect healthy cells from the side effects of chemotherapy and
radiation, said Dr. Fade Mahmoud of the University of South Dakota
School of Medicine, who published a review of the studies this
summer.
Italian researchers, in a long series
of human studies, have shown that melatonin, which appears to have
little toxicity, can boost survival at least modestly in some people
with melanoma and cancers of the lung, breast, kidney and other
organs.
While it's too soon to rush out and buy
over-the-counter melatonin to fight cancer, it is a good idea to
"live a melatonin-friendly lifestyle," said Stevens of
UConn.
That
means going to bed earlier if you're a night owl, making sure the
bedroom is dark, and keeping the light dim in the bathroom if you
make nightly trips there.
|